Vaxfab Enterprises Completes ₹42.88 Crore Preferential Allotment of Warrants and Equity Shares
Vaxfab Enterprises Limited completed allotment of 2,04,04,371 fully convertible warrants and 21,27,689 equity shares on preferential basis at ₹21.02 per share. The warrants were allotted to 50 investors with 18-month conversion period, while equity shares were issued to 41 investors upon warrant conversion. The company's paid-up share capital increased to ₹10,52,76,890 comprising 1,05,27,689 equity shares, with all allotments approved by the Board on January 12, 2026.

*this image is generated using AI for illustrative purposes only.
Vaxfab enterprises Limited has successfully completed a significant capital raising exercise through the allotment of fully convertible warrants and equity shares on a preferential basis. The Board of Directors approved these allotments during their meeting held on January 12, 2026, marking a substantial fundraising milestone for the Ahmedabad-based company.
Warrant Allotment Details
The company allotted 2,04,04,371 fully convertible warrants to 50 investors at ₹21.02 per warrant. These warrants carry conversion rights within a maximum period of 18 months from the allotment date, allowing holders to convert them into equivalent fully paid-up equity shares of ₹10 face value each.
| Parameter: | Details |
|---|---|
| Total Warrants Allotted: | 2,04,04,371 |
| Issue Price: | ₹21.02 per warrant |
| Face Value: | ₹10.00 per share |
| Conversion Period: | Maximum 18 months |
| Number of Investors: | 50 |
| Category: | Public investors |
The warrant allotment includes both individual investors and institutional entities. Major allocations went to entities such as Vintage Diamond LLP (19,02,950 warrants), Sparkling Tradewing LLP (19,98,097 warrants), and Markand Tradeventure LLP (19,55,281 warrants), alongside numerous individual investors.
Equity Share Conversion
Simultaneously, the company allotted 21,27,689 equity shares to 41 investors upon conversion of previously issued warrants. The conversion was executed at the same price of ₹21.02 per share, with investors paying the balance amount of ₹15.765 per warrant (having already paid ₹5.255 at the time of initial warrant allotment).
| Conversion Details: | Amount |
|---|---|
| Equity Shares Issued: | 21,27,689 |
| Conversion Price: | ₹21.02 per share |
| Total Conversion Value: | ₹4,47,24,022.78 |
| Balance Payment per Warrant: | ₹15.765 |
| Number of Converting Investors: | 41 |
Notable conversions included Mitesh Dineshbhai Patel and Seema Miteshkumar Patel, who each converted 3,09,229 warrants into equity shares, and Suresh Jethalal Dama, who converted 1,90,294 warrants while retaining one unconverted warrant.
Impact on Share Capital
Following these allotments, Vaxfab Enterprises' paid-up equity share capital increased significantly. The company's total paid-up capital now stands at ₹10,52,76,890, comprising 1,05,27,689 equity shares of ₹10 face value each. The newly allotted equity shares rank pari-passu with existing equity shares, providing equal rights and privileges to all shareholders.
Regulatory Compliance
The allotments were conducted in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive disclosures including investor details, allotment specifics, and post-allotment shareholding patterns as required under SEBI guidelines. The Board meeting commenced at 8:00 PM and concluded at 8:30 PM on January 12, 2026, with Managing Director Ravindra Ashokbhai Joshi overseeing the proceedings.
Historical Stock Returns for Vaxfab Enterprises
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.29% | +12.74% | +22.86% | +156.48% | +302.71% | +11.36% |
































